Nexplanon Lawsuit Soars as FDA Logs Over 12,000 Adverse Event Reports

The birth control implant lawsuit is gaining momentum in 2026, with thousands of women reporting severe injuries from devices like Nexplanon. Manufacturers Organon and Merck face mounting legal pressure due to reports of implant migration, nerve damage, and breakage. The FDA has logged over 12,000 adverse event reports since launch.

The lawsuit targets the manufacturers for failing to adequately warn patients about serious risks associated with the implants. Plaintiffs claim that the devices are defective and that Organon knew about these flaws but failed to disclose them. The most common target is Nexplanon, made by Organon, which has been used by over 3 million women worldwide since its FDA approval in 2011.

The legal theory is straightforward: the manufacturer knew about serious risks but did not adequately warn patients or doctors. This failure caused real physical harm to thousands of women. The lawsuit aims to compensate those who have suffered from implant migration, nerve damage, and device breakage.